Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01012817
Title Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UCHealth University of Colorado Hospital Aurora Colorado 80045 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451 United States Details
University of Chicago Medicine-Orland Park Orland Park Illinois 60462 United States Details
University of Kansas Clinical Research Center Fairway Kansas 66205 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Parkland Memorial Hospital Dallas Texas 75235 United States Details
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field